By Scott Gottlieb (Original source The Hill)
“During his Senate confirmation hearing in April 2017, Dr. Scott Gottlieb committed himself to “the gold standard of safety and efficacy.”
Over the past two years as head of the Food and Drug Administration (FDA), Commissioner Gottlieb has made good on that promise, and his tenure has been a model for future FDA chiefs.
To his great credit and the benefit of consumers, Gottlieb, whose tenure at the agency ended recently, pursued policies that encouraged competition and choice.
In fall 2016, months before his appointment as FDA chief, Gottlieb foreshadowed his approach to the FDA in testimony at a Senate hearing on the EpiPen price scandal.”
Click here to see more
Chris Miller: Trump admin believes tariff threats have led to more US chip investments
Chris Miller, Tufts Fletcher School associate professor and ‘Chip War’ author, joins ‘Squawk Box’ to discuss the U.S-China trade breakthrough, impact on the chips sector,…
Thought Leader: Chris Miller
Patrick McGee: How Apple invested big, profited greatly and sold itself to China
“Apple in China,” by Patrick McGee, tells the gripping tale of how the computer giant’s decades-long investment in China fueled its spectacular success and, in…
Thought Leader: Patrick McGee
Patrick McGee: How Apple helped China become America’s biggest tech rival
Apple in China: The Capture of the World’s Greatest Company by Patrick McGee (Simon & Schuster) is out on Tuesday. Apple relied on cheap Chinese labour…
Thought Leader: Patrick McGee
